Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance.

MLA

Duda-Madej, Anna, et al. “Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance.” Antibiotics (2079-6382), vol. 12, no. 11, Nov. 2023, p. 1612. EBSCOhost, https://doi.org/10.3390/antibiotics12111612.

APA

Duda-Madej, A., Viscardi, S., & Topola, E. (2023). Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance. Antibiotics (2079-6382), 12(11), 1612. https://doi.org/10.3390/antibiotics12111612

Chicago

Duda-Madej, Anna, Szymon Viscardi, and Ewa Topola. 2023. “Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance.” Antibiotics (2079-6382) 12 (11): 1612. doi:10.3390/antibiotics12111612.